H. Lundbeck A/S (Lundbeck), a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, announced that the last patient has been randomized ...
Morning Overview on MSN
Study suggests a daily multivitamin may slow biological aging
A randomized clinical trial involving 958 older adults suggests that taking a daily multivitamin for two years may produce a small, statistically significant slowdown in two measures of biological ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
For people with exertional-only hypoxemia from fibrotic interstitial lung disease (ILD), use of a portable oxygen ...
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma In this trial, patients with recurrent small HCC (single lesion ≤5 cm) were randomly assigned to receive either SBRT or RFA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results